Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. Fac. Med. (Bogotá) ; 67(4): 635-638, Oct.-Dec. 2019. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1091990

RESUMO

Abstract Introduction: Insulin resistance (IR) is a major risk factor for developing diabetes mellitus type 2 and cardiovascular diseases. In pediatrics, morbidity and mortality associated with these diseases highlights the diagnostic importance of IR for primary care. Objective: To determine Homeostatic Model Assessment Insulin Resistance (HOMA-IR) values and their correlation with BMI-for-age percentile in children and adolescents of the Soconusco region of Chiapas, Mexico. Materials and methods: Cross-sectional study. Overweight and obesity prevalence was determined based on the Body Mass Index (BMI) percentile of112 children (5-19 years old). Glucose and fasting insulin values were quantified and used for estimation of HOMA-IR. Results: The combined prevalence of obesity and overweight was 66%, with insulin (p=0.010) and HOMA-IR (p=0.015) values higher than those of the normal weight group. The HOMA-IR values correlated positively with age (r=0.636), weight (r=0.569), height (r=0.578) and BMI percentile (r=0.198). Conclusions: In the study population, HOMA-IR has a moderately significant correlation with an increase in BMI percentile.


Resumen Introducción. La resistencia a la insulina es un factor importante en el desarrollo de diabetes mellitus tipo 2 y de enfermedades cardiovasculares. En pediatría, su morbimortalidad resalta la importancia diagnóstica con fines de atención primaria. Objetivo. Determinar los valores del homeostatic model assessment insulin resistance (HOMA-IR) y su relación con el índice de masa corporal percentil (IMCp) en niños y adolescentes de la región Soconusco, Chiapas. Materiales y métodos. Estudio transversal. Se determinó sobrepeso y obesidad por IMCp en 112 pacientes pediátricos (5-19 años); se determinaron concentraciones de glucosa y de insulina sérica para estimar el HOMA-IR. Resultados. Se encontró una prevalencia combinada de obesidad y sobrepeso de 66% con valores de insulina (p=0.010) y de HOMA-IR (p=0.015) más elevados que los del grupo de peso normal. El HOMA-IR se correlacionó positivamente con la edad (r=0.636), el peso (r=0.569), la talla (r=0.578) y el IMCp (r=0.198). Conclusión. En la población de estudio, el HOMA-IR presenta una correlación moderadamente significativa con el aumento del IMCp.

2.
Rev Med Inst Mex Seguro Soc ; 50(3): 301-6, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-23182260

RESUMO

OBJECTIVE: to determine the impact of lipid serum abnormalities and the prevalence of metabolic syndrome (MS) in healthy adults. METHODS: a cross-sectional, prospective and observational study in apparently healthy adults aged 20 to 60 years who had at least three of the following criteria: abdominal obesity (waist circumference > 102 cm in men and > 88 cm in women), triglycerides ≥ 150 mg/dL, HDL cholesterol < 40 mg/dL in men and < 50 mg/dL in women, blood pressure ≥ 130/85 mmHg and fasting glucose ≥ 110 mg/dL). RESULTS: the prevalence of MS was 20 %, being higher in women (67.7 %) than men (32.3 %). However, no dependence was found with gender (χ(2)= 2.059, p = 0.151). The age range with a higher prevalence of was 45-49 years. Low HDL cholesterol [HR = 11,059 (3.559, 34.610) p < 0.01], was present in 67.9 % of women and hypertriglyceridemia [HR = 15.53 (4.975, 48.513) p < 0.01] was present in 60.5 % of men. CONCLUSIONS: the results suggested that hypertriglyceridemia and hypoalphalipoproteinemia are high impact factors for MS in adults.


Assuntos
Hipertrigliceridemia/complicações , Hipoalfalipoproteinemias/complicações , Síndrome Metabólica/complicações , Síndrome Metabólica/diagnóstico , Síndrome Metabólica/epidemiologia , Adulto , HDL-Colesterol/sangue , Estudos Transversais , Feminino , Humanos , Hipertrigliceridemia/sangue , Hipoalfalipoproteinemias/sangue , Masculino , Síndrome Metabólica/sangue , Pessoa de Meia-Idade , Prevalência , Estudos Prospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...